Literature DB >> 27314752

A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan.

Yoshito Kamijo1, Michiko Takai1, Yuji Fujita2, Tetsuya Sakamoto3.   

Abstract

BACKGROUND: In Japan, fatalities among patients who experienced an acute reaction following self-administration of novel psychoactive substances (NPS) have been more frequently reported since June 2014.
OBJECTIVE: This survey aimed to document and analyze trends in NPS consumption in emergency patients.
METHODS: We conducted a multicenter retrospective survey of patients who were transported to emergency facilities after consuming NPS-containing products between January 2013 and December 2014. Letters requesting participation were sent to 467 emergency facilities, and questionnaires were mailed to facilities that agreed to participate.
RESULTS: We surveyed 589 patients from 85 (18.2%) facilities. Most patients were male (89.6%) and young (median age, 30 years), and inhaled (88%) NPS contained in herbal products (80.5%). Harmful behavior was observed at the scene of acute reaction, including violence (6.9%), traffic accidents (4.9%), and self-injury or suicidal attempts (1.1%). Other than neuropsychiatric and physical symptoms, many patients also had physical complications such as rhabdomyolysis (17.5%), liver injury (12.4%), acute kidney injury (9%), and physical injury (1.9%). Of the 256 patients (43.5%) admitted to hospitals, 35 (5.9%) were hospitalized for seven or more days. Most patients (93.2%) completely recovered, although a few (1.4%) died. However, synthetic cannabinoids and synthetic cathinones were only detected in the blood of five patients.
CONCLUSION: Consumption of NPS-containing products have been associated with harmful behaviors such as violence and traffic accidents, physical complications (e.g., rhabdomyolysis, liver injury), death, or physical and neuropsychiatric symptoms. Compared to a previous survey (2006-2012), the present survey revealed more severe toxicity.

Entities:  

Keywords:  Acute kidney injury; liver injury; rhabdomyolysis; synthetic cannabinoid; synthetic cathinone

Mesh:

Substances:

Year:  2016        PMID: 27314752     DOI: 10.1080/00952990.2016.1176177

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  5 in total

1.  Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes.

Authors:  Jeremy Carlier; Xingxing Diao; Cristina Sempio; Marilyn A Huestis
Journal:  AAPS J       Date:  2017-01-09       Impact factor: 4.009

2.  Synthetic cannabinoid CP-55,940 induces apoptosis in a human skeletal muscle model via regulation of CB1 receptors and L-type Ca2+ channels.

Authors:  Ken-Ichi Tomiyama; Masahiko Funada
Journal:  Arch Toxicol       Date:  2020-11-10       Impact factor: 5.153

3.  Designers Drugs-A New Challenge to Emergency Departments-An Observational Study in Poland.

Authors:  Rakesh Jalali; Paula Dmochowska; Izabela Godlewska; Justyna Balmas; Katarzyna Młynarska; Krzysztof Narkun; Andrzej Zawadzki; Marcin Wojnar
Journal:  Medicina (Kaunas)       Date:  2020-07-17       Impact factor: 2.430

Review 4.  Acute Kidney Injury (AKI) in Young Synthetic Cannabinoids Abusers.

Authors:  Stefano D'Errico; Martina Zanon; Davide Radaelli; Monica Concato; Martina Padovano; Matteo Scopetti; Paola Frati; Vittorio Fineschi
Journal:  Biomedicines       Date:  2022-08-10

5.  The influence of tightening regulations on patients with new psychoactive substance-related disorders in Japan.

Authors:  Yuko Tanibuchi; Toshihiko Matsumoto; Daisuke Funada; Takuya Shimane
Journal:  Neuropsychopharmacol Rep       Date:  2018-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.